High-quality statin trials support the 2013 American College of Cardiology/American Heart Association cholesterol guidelines after the HOPE-3 trial (heart outcomes prevention evaluation-3): MESA (The multiethnic study of atherosclerosis)

Martin Bødtker Mortensen, Matthew Budoff, Dong Li, Khurram Nasir, Michael J. Blaha, Veit Sandfort, Carlos Jose Rodriguez, Pamela Ouyang, Erling Falk

Research output: Contribution to journalLetter

4 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1863-1865
Number of pages3
JournalCirculation
Volume136
Issue number19
DOIs
StatePublished - Jun 23 2017
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Atherosclerosis
Cholesterol
Guidelines

Keywords

  • Cardiovascular diseases
  • Guideline
  • Hydroxymethylglutaryl-CoA reductase inhibitors
  • Lipoproteins
  • Primary prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

High-quality statin trials support the 2013 American College of Cardiology/American Heart Association cholesterol guidelines after the HOPE-3 trial (heart outcomes prevention evaluation-3) : MESA (The multiethnic study of atherosclerosis). / Mortensen, Martin Bødtker; Budoff, Matthew; Li, Dong; Nasir, Khurram; Blaha, Michael J.; Sandfort, Veit; Rodriguez, Carlos Jose; Ouyang, Pamela; Falk, Erling.

In: Circulation, Vol. 136, No. 19, 23.06.2017, p. 1863-1865.

Research output: Contribution to journalLetter

Mortensen, Martin Bødtker ; Budoff, Matthew ; Li, Dong ; Nasir, Khurram ; Blaha, Michael J. ; Sandfort, Veit ; Rodriguez, Carlos Jose ; Ouyang, Pamela ; Falk, Erling. / High-quality statin trials support the 2013 American College of Cardiology/American Heart Association cholesterol guidelines after the HOPE-3 trial (heart outcomes prevention evaluation-3) : MESA (The multiethnic study of atherosclerosis). In: Circulation. 2017 ; Vol. 136, No. 19. pp. 1863-1865.
@article{a8ef7d50faea46f0ab70c5916bc20bcf,
title = "High-quality statin trials support the 2013 American College of Cardiology/American Heart Association cholesterol guidelines after the HOPE-3 trial (heart outcomes prevention evaluation-3): MESA (The multiethnic study of atherosclerosis)",
keywords = "Cardiovascular diseases, Guideline, Hydroxymethylglutaryl-CoA reductase inhibitors, Lipoproteins, Primary prevention",
author = "Mortensen, {Martin B{\o}dtker} and Matthew Budoff and Dong Li and Khurram Nasir and Blaha, {Michael J.} and Veit Sandfort and Rodriguez, {Carlos Jose} and Pamela Ouyang and Erling Falk",
year = "2017",
month = "6",
day = "23",
doi = "10.1161/CIRCULATIONAHA.117.029381",
language = "English (US)",
volume = "136",
pages = "1863--1865",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "19",

}

TY - JOUR

T1 - High-quality statin trials support the 2013 American College of Cardiology/American Heart Association cholesterol guidelines after the HOPE-3 trial (heart outcomes prevention evaluation-3)

T2 - MESA (The multiethnic study of atherosclerosis)

AU - Mortensen, Martin Bødtker

AU - Budoff, Matthew

AU - Li, Dong

AU - Nasir, Khurram

AU - Blaha, Michael J.

AU - Sandfort, Veit

AU - Rodriguez, Carlos Jose

AU - Ouyang, Pamela

AU - Falk, Erling

PY - 2017/6/23

Y1 - 2017/6/23

KW - Cardiovascular diseases

KW - Guideline

KW - Hydroxymethylglutaryl-CoA reductase inhibitors

KW - Lipoproteins

KW - Primary prevention

UR - http://www.scopus.com/inward/record.url?scp=85021299585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021299585&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.117.029381

DO - 10.1161/CIRCULATIONAHA.117.029381

M3 - Letter

C2 - 28634218

AN - SCOPUS:85021299585

VL - 136

SP - 1863

EP - 1865

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 19

ER -